ANEB
Anebulo Pharmaceuticals Inc
NASDAQ: ANEB · HEALTHCARE · BIOTECHNOLOGY
$0.43
-11.78% today
Updated 2026-04-29
Market cap
$22.43M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.18
Dividend yield
—
52W range
$0 – $3
Volume
0.0M
Anebulo Pharmaceuticals Inc (ANEB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-150772.00 | $-4.87M | $-5.44M | $-9.68M | $-8.09M | $-6.35M |
| Capital expenditures | $2.00 | $0.00 | $4.00 | $0.00 | $1.00 | $3.00 |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | — | $199947.00 | $480661.00 | $884723.00 | $758884.00 | $1.45M |
| Free cash flow | $-150774.00 | $-4.87M | $-5.44M | $-9.68M | $-8.09M | $-6.35M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | — | $8.21M | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |